IMMUNEONCO-B(01541) has granted a loan of 13.7247 million yuan.

IMMUNEONCO-B (01541) announced that on February 10, 2026, the company entered into a loan agreement with borrower Dr. Tian Wenzhi. According to this agreement, the company agreed to provide a loan of RMB 13.7247 million to the borrower. The terms of the loan agreement (including the applicable interest rate) were reached after fair negotiations between the company and the borrower, considering current market rates and practices. The loan agreement was entered into by the company after considering the following factors: the group's financial situation is good, with sufficient internal resources to provide funds for the loan; providing the loan will not affect the group's working capital or daily operations; and the loan will generate stable interest income.